Metralindole

From Wikipedia, the free encyclopedia
Metralindole
Systematic (IUPAC) name
2,4,5,6-tetrahydro-9-methoxy-4-methyl-1H-3,4,6a-triazafluoranthene
Clinical data
Legal status Prescription only
Routes Oral
Identifiers
CAS number 53734-79-5
ATC code None
PubChem CID 68713
ChemSpider 61964
UNII 2QW3FL6OPA YesY
Chemical data
Formula C15H17N3O 
Mol. mass 255.32 g/mol

Metralindole (Inkazan) is a reversible inhibitor of monoamine oxidase A (RIMA) which was investigated in Russia as a potential antidepressant.[1] It is structurally and pharmacologically related to pirlindole.

See also

References

  1. Andreeva NI, Golovina SM, Faermark MF, Shvarts GIa, Mashkovskiĭ MD (1991). "[The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine]". Farmakologiia I Toksikologiia (in Russian) 54 (2): 38–40. PMID 1884793. 



This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.